Rtnew LF Artemether and Lumefantrine Tablets

Get a Price/Quote

MOQ : 10 Boxes

Rtnew LF Artemether and Lumefantrine Tablets Specification

Life Span
Refer to expiry date on package

Packaging Type
Box

Origin of Medicine
Export Quality / International (As shown by presence of multiple national flags)

Indication
Malaria infection caused by Plasmodiumfalciparum

Pacakaging (Quantity Per Box)
6 Tablets per Box

Brand Name
RTNEW-LF

Salt Composition
Artemether + Lumefantrine

Dosage Form
Oral Tablet

Drug Type
Allopathic

Ingredients
Artemether and Lumefantrine

Physical Form
Tablet

Function
Anti-malarial

Recommended For
Treatment of Malaria

Dosage
As directed by the physician

Dosage Guidelines
Take with food or as prescribed by a healthcare professional

Quantity
6 Tablets

Storage Instructions
Store in a cool, dry place away from sunlight

Formulation Type
Fixed-dose combination

Prescription Required
Yes

Regulatory Approval
Manufacturing details available as per country regulations

Shelf Life
Check package for expiry

Administration Route
Oral

Tablet Shape
Film-coated tablets

Marketed For
Export to USA, UK, Canada, Australia, Europe

Colour
Purple and white box with green RTNEW-LF label

Rtnew LF Artemether and Lumefantrine Tablets Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Rtnew LF Artemether and Lumefantrine Tablets About

Ending Soon: Discover the new release of RTNEW-LF Artemether and Lumefantrine Tablets, a superlative solution for malaria treatment, now available in a radiant purple and white box with a striking green RTNEW-LF label. This fixed-dose, peerless tablet is prescribed for adults and children, offering customizable dosing as advised by a physician. Each film-coated tablet combines artemether and lumefantrine for optimal efficacy. Marketed globally, the export-quality product fulfills all regulatory requirements per destination. Store in a cool, dry place, and always check the shelf life for continued potency.

Versatile Application and Usage for Malaria

RTNEW-LF Artemether and Lumefantrine Tablets are crafted for administration via the oral route and present in easily ingestible, film-coated form. Used as an anti-malarial agent, their application surface extends to both adults and children for the treatment of malaria. The product is recommended strictly under physician guidance, ensuring precise dosage for effective therapeutic outcomes. Designed for user convenience, it is packaged with clear usage and application instructions, optimizing its role in malaria management.

Certifications, Main Export Markets, and Sample Policy

RTNEW-LF Artemether and Lumefantrine Tablets come with comprehensive certifications aligned with country-specific regulations, ensuring quality and safety. Acknowledged in superlative export markets-including the USA, UK, Canada, Australia, and Europe-these tablets reflect an international standard. The asking price and overall expenditure are competitive for bulk orders. For evaluation, samples can be made available on request, providing assurance and transparency to global partners prior to purchase.

FAQ's of Rtnew LF Artemether and Lumefantrine Tablets:

Q: How should RTNEW-LF Artemether and Lumefantrine Tablets be administered?

A: The tablets should be taken orally and always with food, following the exact dosage and schedule provided by your healthcare professional.

Q: What is the primary benefit of using RTNEW-LF Artemether and Lumefantrine Tablets?

A: These tablets offer a fixed-dose combination for the effective treatment of malaria caused by Plasmodium falciparum, suitable for both adults and children.